A form of avascular necrosis where there is death of a portion of the bone that is thought to be caused by nitrogen embolism.
Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation for dysbaric osteonecrosis is limited primarily due to its rarity and the lack of systematic clinical studies. As this condition affects a small number of individuals, comprehensive research and clinical characterization have not been extensively conducted. This can lead to feelings of isolation, but ongoing research may provide more insights in the future.
To navigate dysbaric osteonecrosis, seek specialists such as orthopedic surgeons or rehabilitation physicians with experience in avascular necrosis and diving-related injuries. You may also explore participation in clinical trials to access potential new treatments. For more information, the National Organization for Rare Disorders (NORD) offers resources at rarediseases.org. Additionally, consider reaching out to academic medical centers that may have ongoing research or natural history studies related to this condition.
Currently, there are three orphan drugs designated for dysbaric osteonecrosis, including autologous adult live cultured osteoblasts, human allogeneic bone marrow derived osteoblastic cells, and tissue repair cells obtained from autologous bone marrow. There is also one active clinical trial related to this condition, which can be explored further at ClinicalTrials.gov. This research represents hope for future treatment options and better understanding of the disease.
Actionable guidance for navigating care for dysbaric osteonecrosis
To navigate dysbaric osteonecrosis, seek specialists such as orthopedic surgeons or rehabilitation physicians with experience in avascular necrosis and diving-related injuries. You may also explore participation in clinical trials to access potential new treatments. For more information, the National Organization for Rare Disorders (NORD) offers resources at rarediseases.org. Additionally, consider reaching out to academic medical centers that may have ongoing research or natural history studies related to this condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation for dysbaric osteonecrosis is limited primarily due to its rarity and the lack of systematic clinical studies. As this condition affects a small number of individuals, comprehensive research and clinical characterization have not been extensively conducted. This can lead to feelings of isolation, but ongoing research may provide more insights in the future.
To navigate dysbaric osteonecrosis, seek specialists such as orthopedic surgeons or rehabilitation physicians with experience in avascular necrosis and diving-related injuries. You may also explore participation in clinical trials to access potential new treatments. For more information, the National Organization for Rare Disorders (NORD) offers resources at rarediseases.org. Additionally, consider reaching out to academic medical centers that may have ongoing research or natural history studies related to this condition.
Currently, there are three orphan drugs designated for dysbaric osteonecrosis, including autologous adult live cultured osteoblasts, human allogeneic bone marrow derived osteoblastic cells, and tissue repair cells obtained from autologous bone marrow. There is also one active clinical trial related to this condition, which can be explored further at ClinicalTrials.gov. This research represents hope for future treatment options and better understanding of the disease.
Actionable guidance for navigating care for dysbaric osteonecrosis
To navigate dysbaric osteonecrosis, seek specialists such as orthopedic surgeons or rehabilitation physicians with experience in avascular necrosis and diving-related injuries. You may also explore participation in clinical trials to access potential new treatments. For more information, the National Organization for Rare Disorders (NORD) offers resources at rarediseases.org. Additionally, consider reaching out to academic medical centers that may have ongoing research or natural history studies related to this condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation for dysbaric osteonecrosis is limited primarily due to its rarity and the lack of systematic clinical studies. As this condition affects a small number of individuals, comprehensive research and clinical characterization have not been extensively conducted. This can lead to feelings of isolation, but ongoing research may provide more insights in the future.
To navigate dysbaric osteonecrosis, seek specialists such as orthopedic surgeons or rehabilitation physicians with experience in avascular necrosis and diving-related injuries. You may also explore participation in clinical trials to access potential new treatments. For more information, the National Organization for Rare Disorders (NORD) offers resources at rarediseases.org. Additionally, consider reaching out to academic medical centers that may have ongoing research or natural history studies related to this condition.
Currently, there are three orphan drugs designated for dysbaric osteonecrosis, including autologous adult live cultured osteoblasts, human allogeneic bone marrow derived osteoblastic cells, and tissue repair cells obtained from autologous bone marrow. There is also one active clinical trial related to this condition, which can be explored further at ClinicalTrials.gov. This research represents hope for future treatment options and better understanding of the disease.
Actionable guidance for navigating care for dysbaric osteonecrosis
To navigate dysbaric osteonecrosis, seek specialists such as orthopedic surgeons or rehabilitation physicians with experience in avascular necrosis and diving-related injuries. You may also explore participation in clinical trials to access potential new treatments. For more information, the National Organization for Rare Disorders (NORD) offers resources at rarediseases.org. Additionally, consider reaching out to academic medical centers that may have ongoing research or natural history studies related to this condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 31, 2026
Consider asking your healthcare providers these condition-specific questions
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.